A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Abroad (travel likely)RecruitingPHASE1
Conditions
Sickle Cell Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Julie Kanter, MD)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Fuad El Rassi, MD)Augusta University, Augusta, Georgia, United States
Contact: Principal Investigator (Abdullah Kutlar, MD)Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis, Indiana, United States
Contact: Principal Investigator (Amro Elshoury, MD)Mount Sinai Hospital, New York, New York, United States
Contact: Principal Investigator (Susanna Curtis, MD, PhD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (John Strouse)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Charles Quinn, MD, MS)